HomeAI · summaries
Storia in 6 fonti
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
axios.com
Eli Lilly agrees to $3.8B psychedelic buy
The AtaiBeckley acquisition would be the largest psychedelic deal to date.
- ·
benzinga.com
AtaiBeckley Shares Surge as Eli Lilly Seals $3.8B Acquisition Deal - Eli Lilly (NYSE:LLY), AtaiBeckley (N
Lilly will acquire AtaiBeckley in a deal worth up to $3.8 billion, adding late-stage depression therapies to its mental health pipeline.
- ·
www1.folha.uol.com.br
Dona da Mounjaro compra empresa que produz antidepressivos por US$ 3,8 bilhões
Eli Lilly adquire AtaiBeckley, que está estudando spray nasal que utiliza alucinógeno
- ·
oglobo.globo.com
Fabricante do Monjauro fecha acordo de US$ 3,8 bi para comprar empresa de medicamentos psicodélicos
Acordo reforça a presença de longa data da Lilly na área de neurociências, segmento no qual a empresa revolucionou o tratamento da depressão há cerca de três décadas com o…
- ·
cnbc.com
The market for psychedelic drugs to treat mental health conditions gets a big buy signal
Eli Lilly's acquisition of psychedelic drug maker AtaiBeckley extends Big Pharma's embrace of a stigmatized class of medications for treating mental health.
- ·
forbes.com
Big Pharma And Psychedelic Medicine: Eli Lilly’s $3.8 Billion Bet
Eli Lilly's acquisition of AtaiBeckley for up to $3.8 billion, marks a pivotal moment for psychedelic medicine.